EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease

Qasim Al-Orjani, Lubna A Alshriem, Gillian Gallagher, Raghad Buqaileh, Neela Azizi, Wissam AbouAlaiwi iD

Cells · 2025

DOI: 10.3390/cells14151203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Qasim Al-Orjani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA. Hauptthemen laut MEDLINE: Polycystic Kidney Diseases, Polycystic Kidney, Autosomal Dominant. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, American Foundation of Pharmaceutical Education (AFPE) Gateway to Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic ciliopathy resulting from loss-of-function mutations in the PKD1 and PKD2 genes, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. PC1 and PC2 regulate mechanosensation, calcium signaling, and key pathways controlling tubular epithelial structure and function. Loss of PC1/PC2 disrupts calcium homeostasis, elevates cAMP, and activates proliferative cascades such as PKA–B-Raf–MEK–ERK, mTOR, and Wnt, driving cystogenesis via epithelial proliferation, impaired apoptosis, fluid secretion, and fibrosis. Recent evidence also implicates novel signaling axes in ADPKD progression including, the Hippo pathway, where dysregulated YAP/TAZ activity enhances c-Myc-mediated proliferation; the stimulator of interferon genes (STING) pathway, which is activated by mitochondrial DNA release and linked to NF-κB-driven inflammation and fibrosis; and the TWEAK/Fn14 pathway, which mediates pro-inflammatory and pro-apoptotic responses via ERK and NF-κB activation in tubular cells. Mitochondrial dysfunction, oxidative stress, and maladaptive extracellular matrix remodeling further exacerbate disease progression. A refined understanding of ADPKD’s complex signaling networks provides a foundation for precision medicine and next-generation therapeutics. This review gathers recent molecular insights and highlights both established and emerging targets to guide targeted treatment strategies in ADPKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney DiseasesPolycystic Kidney, Autosomal DominantHumansAnimalsSignal TransductionTRPP Cation Channels

Stichwörter der Autor:innen

ADPKDPC1/PC2PKDWntapoptosiscAMPcalciumciliacystogenesisfibrosismTORmitochondria

Substanzen

TRPP Cation Channels

Autor:innen und Institutionen

  • Department of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43614, USA.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.

ORCID-Profile: Wissam AbouAlaiwi

Förderung

  • NIA NIH HHS
  • NHLBI NIH HHS
  • American Foundation of Pharmaceutical Education (AFPE) Gateway to Research Award
  • University of Toledo Office of Research and Sponsored Programs
  • Alzheimer’s Association
  • NIA
  • NHLBI

Zitieren

APA

Al-Orjani, Q., Alshriem, L. A., Gallagher, G., Buqaileh, R., Azizi, N., & AbouAlaiwi, W. (2025). Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease. Cells. https://doi.org/10.3390/cells14151203

Vancouver

Al-Orjani Q, Alshriem LA, Gallagher G, Buqaileh R, Azizi N, AbouAlaiwi W. Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease. Cells. 2025. doi:10.3390/cells14151203

BibTeX
@article{AlOrjani2025,
  author = {Al-Orjani, Qasim and Alshriem, Lubna A and Gallagher, Gillian and Buqaileh, Raghad and Azizi, Neela and AbouAlaiwi, Wissam},
  title = {Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14151203}
}
Kostenlos starten →